SCHORNO DEAN L (EVP &Chief Financial Officer) reported 1 transaction at RIGEL PHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 2/4/2026ACC: 0000905148-26-000497
Officer· EVP &Chief Financial Officer
Since Jan 2019
-5.49K
Net shares
Net seller
$197.6K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
5.49K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5.49K
Price / share
$36.01
Trade value
$197.62K
% of position
8.5%
2/2/2026
64.73K→59.25K
Total
Net shares
−5.49K
Net value
-$197.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | F · Tax Withholding | −5.49K | $36.01 | $197.62K | 8.5% | 64.73K | 59.25K |
| Total | −5.49K | -$197.62K | ||||||
Derivative Transactions0
No derivative transactions reported